Latest / US News Today | 2 Min News | The Daily News Now!
FDA Panel Votes to Expand Peptide Access | US News
A controversial FDA advisory panel narrowly voted 8-6 to allow specialty pharmacies to compound BPC-157, a wildly popular but unproven peptide touted for longevity and wellness, despite FDA scientists warning of insufficient evidence for its medical value. The decision, backed by Health Secretary Robert F. Kennedy Jr., who champions peptide use, came amid industry lobbying and panel members with ties to the peptide world. Six more peptides are up for vote this week, with outcomes likely to favor Kennedy’s push for broader access — possibly through temporary policy protections for pharmacies…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.